Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30584777 | 1.00 | MAPT (0.61) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL30584782 | 0.88 | MAPT (0.62) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL30584785 | 0.88 | MAPT (0.62) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL25433010 | 0.88 | MAPT (0.62) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL25433838 | 0.88 | MAPT (0.57) | MAPTMEN1KMT2ATP53LMNA | |
| SCHEMBL25434895 | 0.85 | MAPT (0.58) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL30585061 | 0.85 | MAPT (0.58) | MAPTMEN1KMT2ATP53GRM5 | |
| SCHEMBL25435527 | 0.78 | MEN1 (0.68) | MAPTMEN1KMT2ATP53LMNA | |
| SCHEMBL25433674 | 0.78 | MAPT (0.58) | MAPTMEN1KMT2ALMNAPOLB | |
| SCHEMBL20117011 | 0.75 | MAPT (0.61) | MAPTMEN1KMT2ATP53LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177700-A2 | C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER | ANIMA BIOTECH INC. (US) | 2023-09-21 | — | — | WO | disclosed |